CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Rokit Healthcare Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Rokit Healthcare Inc
12F, 9, Digital-ro 10-gil, Geumcheon-gu
Phone: +82 218997296p:+82 218997296 SEOUL, 08514  South Korea Ticker: 376900376900

Business Summary
ROKIT HEALTHCARE Inc. is a Korea-based company primarily engaged in the development and sale of medical devices, supplies, and healthcare products. Through its artificial intelligence (AI)-driven organ regeneration platform, the Company mainly engages in the development of personalized algorithms based on artificial intelligence and data, as well as research and development in 3-dimensional (3D) cell and tissue printing and regenerative niche bio-ink technology. The Company's product portfolio consists primarily of medical 3D bioprinters and single-use medical device kits. The medical 3D bioprinters are used to fabricate 3D structures from biocompatible materials or biomaterials. The single-use medical device kits contain the essential components and bio-inks required for 3D bioprinting procedure. Additionally, the Company provides extracellular matrix (ECM) products used for cell and tissue culture in research applications.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202612/31/2025Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Chief Executive Officer Seok HwanYou 68

General Information
Outstanding Shares: 17,448,263 (As of 10/20/2026)
Shareholders: 38,283
Stock Exchange: KDQ
Fax Number: +82 28650182


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, November 21, 2026